Table of Contents Author Guidelines Submit a Manuscript
Sarcoma
Volume 2006, Article ID 87367, 9 pages
http://dx.doi.org/10.1155/SRCM/2006/87367
Review Article

The Radiation Response of Sarcomas by Histologic Subtypes: A Review With Special Emphasis Given to Results Achieved With Razoxane

Department of Radiooncology, General Hospital, Carinagasse 47, Feldkirch 6800, Austria

Received 25 June 2005; Revised 6 January 2006; Accepted 14 February 2006

Copyright © 2006 Walter Rhomberg. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J D Slater, M D McNeese, and L J Peters, “Radiation therapy for unresectable soft tissue sarcomas,” International Journal of Radiation Oncology, Biology, Physics, vol. 12, no. 10, pp. 1729–1734, 1986. View at Google Scholar
  2. J E Tepper and H D Suit, “Radiation therapy alone for sarcoma of soft tissue,” Cancer, vol. 56, no. 3, pp. 475–479, 1985. View at Publisher · View at Google Scholar
  3. H A Gilbert, A R Kagan, and J Winkley, “Soft tissue sarcomas of the extremities: their natural history, treatment, and radiation sensitivity,” Journal of Surgical Oncology, vol. 7, no. 4, pp. 303–317, 1975. View at Publisher · View at Google Scholar
  4. L Cohen, F Hendrickson, J A Mansell et al., “Response of sarcomas of bone and of soft tissue to neutron beam therapy,” International Journal of Radiation Oncology, Biology, Physics, vol. 10, no. 6, pp. 821–824, 1984. View at Google Scholar
  5. T Kamada, H Tsujii, H Tsuji et al., “Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas,” Journal of Clinical Oncology, vol. 20, no. 22, pp. 4466–4471, 2002. View at Publisher · View at Google Scholar
  6. H D Suit, M Goitein, J Munzenrider et al., “Increased efficacy of radiation therapy by use of proton beam,” Strahlentherapie und Onkologie, vol. 166, no. 1, pp. 40–44, 1990. View at Google Scholar
  7. A Wambersie, “The European experience in neutron therapy at the end of 1981,” International Journal of Radiation Oncology, Biology, Physics, vol. 8, no. 12, pp. 2145–2152, 1982. View at Google Scholar
  8. T J Kinsella and E Glatstein, “Clinical experience with intravenous radiosensitizers in unresectable sarcomas,” Cancer, vol. 59, no. 5, pp. 908–915, 1987. View at Publisher · View at Google Scholar
  9. W Rhomberg, E OM Hassenstein, and D Gefeller, “Radiotherapy vs. radiotherapy and razoxane in the treatment of soft tissue sarcomas: final results of a randomized study,” International Journal of Radiation Oncology, Biology, Physics, vol. 36, no. 5, pp. 1077–1084, 1996. View at Publisher · View at Google Scholar
  10. M F Brennan, K M Alektiar, and R G Maki, “Sarcoma of the soft tissue and bone,” in Cancer Principles & Practice of Oncology, V T Jr De Vita, S Hellman, and S A Rosenberg, Eds., p. 1865, Lippincott Williams & Wilkins, Philadelphia, Pa, 6th edition, 2001. View at Google Scholar
  11. V T Jr De Vita, S Hellman, and S A Rosenberg, Eds., Cancer. Principles & Practice of Oncology, V T Jr De Vita, S Hellman, and S A Rosenberg, Eds., Lippincott Williams & Wilkins, Philadelphia, Pa, 4th edition, 1993.
  12. F C Eilber, G Rosen, J Eckardt et al., “Treatment-induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas,” Journal of Clinical Oncology, vol. 19, no. 13, pp. 3203–3209, 2001. View at Google Scholar
  13. C G Willett, A L Schiller, H D Suit, H J Mankin, and A Rosenberg, “The histologic response of soft tissue sarcoma to radiation therapy,” Cancer, vol. 60, no. 7, pp. 1500–1504, 1987. View at Publisher · View at Google Scholar
  14. M T Ballo, G K Zagars, P Pisters, and A Pollack, “The role of radiation therapy in the management of dermatofibrosarcoma protuberans,” International Journal of Radiation Oncology, Biology, Physics, vol. 40, no. 4, pp. 823–827, 1998. View at Publisher · View at Google Scholar
  15. B Windeyer, S Dische, and C M Mansfield, “The place of radiotherapy in the management of fibrosarcoma of the soft tissues,” Clinical Radiology, vol. 17, no. 1, pp. 32–40, 1966. View at Publisher · View at Google Scholar
  16. R DH Ryall, I WF Hanham, K A Newton, K Hellmann, D M Brinkley, and O K Hjertaas, “Combined treatment of soft tissue and osteosarcomas by radiation and ICRF 159,” Cancer, vol. 34, no. 4, pp. 1040–1045, 1974. View at Publisher · View at Google Scholar
  17. G Pitson, P Robinson, D Wilke et al., “Radiation response: an additional unique signature of myxoid liposarcoma,” International Journal of Radiation Oncology, Biology, Physics, vol. 60, no. 2, pp. 522–526, 2004. View at Publisher · View at Google Scholar
  18. R Belgrad, N Elbadawi, and P Rubin, “Uterine sarcoma,” Radiology, vol. 114, no. 1, pp. 181–188, 1975. View at Google Scholar
  19. O M Salazar and M E Dunne, “The role of radiation therapy in the management of uterine sarcomas,” International Journal of Radiation Oncology, Biology, Physics, vol. 6, no. 7, pp. 899–902, 1980. View at Google Scholar
  20. H D Weitmann, T H Knocke, H Kucera, and R Pötter, “Radiation therapy in the treatment of endometrial stromal sarcoma,” International Journal of Radiation Oncology, Biology, Physics, vol. 49, no. 3, pp. 739–748, 2001. View at Publisher · View at Google Scholar
  21. A S Pavlov, K N Kostromina, E P Simakina, A V Stolbovoiĭ, and G A Frank, “Cure of a patient with prostatic leiomyosarcoma with radiotherapy,” Urologiia, no. 4, pp. 61–63, 2004. View at Google Scholar
  22. Y Sakano, J Yonese, Y Okubo et al., “Leiomyosarcoma of the prostate: a case report of remission for 9 years by radiotherapy,” Hinyokika Kiyo. Acta Urologica Japonica, vol. 41, no. 8, pp. 629–632, 1995. View at Google Scholar
  23. G P Jin, M Zhao, J X Qi, H G Jiang, and S G Yu, “Malignant fibrous histiocytoma of head and neck: clinical analysis of 21 cases,” Ai Zheng, vol. 22, no. 5, pp. 523–525, 2003. View at Google Scholar
  24. K Shinjo, “Analysis of prognostic factors and chemotherapy of malignant fibrous histiocytoma of soft tissue: a preliminary report,” Japanese Journal of Clinical Oncology, vol. 24, no. 3, pp. 154–159, 1994. View at Google Scholar
  25. M Peiper, D Zurakowski, W T Knoefel, and J R Izbicki, “Malignant fibrous histiocytoma of the extremities and trunk: an institutional review,” Surgery, vol. 135, no. 1, pp. 59–66, 2004. View at Publisher · View at Google Scholar
  26. A Belal, A Kandil, A Allam et al., “Malignant fibrous histiocytoma: a retrospective study of 109 cases,” American Journal of Clinical Oncology, vol. 25, no. 1, pp. 16–22, 2002. View at Publisher · View at Google Scholar
  27. M T Reagan, L J Clowry, J D Cox, and N Rangala, “Radiation therapy in the treatment of malignant fibrous histiocytoma,” International Journal of Radiation Oncology, Biology, Physics, vol. 7, no. 3, pp. 311–315, 1981. View at Google Scholar
  28. A Ferrari, A Gronchi, M Casanova et al., “Synovial sarcoma: a retrospective analysis of 271 patients of all ages treated at a single institution,” Cancer, vol. 101, no. 3, pp. 627–634, 2004. View at Publisher · View at Google Scholar
  29. G Rosen, C Forscher, S Lowenbraun et al., “Synovial sarcoma: uniform response of metastases to high dose ifosfamide,” Cancer, vol. 73, no. 10, pp. 2506–2511, 1994. View at Publisher · View at Google Scholar
  30. A R Kagan, N B Friedman, and H L Jaffe, “Synovial sarcoma: an analysis of its response to radiation,” Journal of Surgical Oncology, vol. 3, no. 4, pp. 379–385, 1971. View at Publisher · View at Google Scholar
  31. J H Carson, A R Harwood, B J Cummings et al., “The place of radiotherapy in the treatment of synovial sarcoma,” International Journal of Radiation Oncology, Biology, Physics, vol. 7, no. 1, pp. 49–53, 1981. View at Google Scholar
  32. C A Holden, M F Spittle, and E W Jones, “Angiosarcoma of the face and scalp, prognosis and treatment,” Cancer, vol. 59, no. 5, pp. 1046–1057, 1987. View at Publisher · View at Google Scholar
  33. D Ladurner, M Tötsch, T Luze, I Bangerl, P Sandbichler, and K W Schmid, “Das maligne Hämangioendotheliom der Schilddrüse. Pathologie, Klinik und Prognose,” Wiener Klinische Wochenschrift, vol. 102, no. 9, pp. 256–259, 1990. View at Google Scholar
  34. T M Pawlik, A F Paulino, C J McGinn et al., “Cutaneous angiosarcoma of the scalp: a multidisciplinary approach,” Cancer, vol. 98, no. 8, pp. 1716–1726, 2003. View at Publisher · View at Google Scholar
  35. A J Salsbury, K Burrage, and K Hellmann, “Histological analysis of the antimetastatic effect of (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane,” Cancer Research, vol. 34, no. 4, pp. 843–849, 1974. View at Google Scholar
  36. W H Morrison, R M Byers, A S Garden, H L Evans, K K Ang, and L J Peters, “Cutaneous angiosarcoma of the head and neck: a therapeutic dilemma,” Cancer, vol. 76, no. 2, pp. 319–327, 1995. View at Publisher · View at Google Scholar
  37. J R Ward, S J Feigenberg, N P Mendenhall, R B Jr Marcus, and W M Mendenhall, “Radiation therapy for angiosarcoma,” Head and Neck, vol. 25, no. 10, pp. 873–878, 2003. View at Publisher · View at Google Scholar
  38. W J Graham and C R Jr Bogardus, “Angiosarcoma treated with radiation therapy alone,” Cancer, vol. 48, no. 4, pp. 912–914, 1981. View at Publisher · View at Google Scholar
  39. R Pötter, P Baumgart, H Greve, and E Schnepper, “Primary angiosarcoma of the heart,” Thoracic and Cardiovascular Surgeon, vol. 37, no. 6, pp. 374–378, 1989. View at Google Scholar
  40. R J Mark, J C Poen, L M Tran, Y S Fu, and G F Juillard, “Angiosarcoma: a report of 67 patients and a review of the literature,” Cancer, vol. 77, no. 11, pp. 2400–2406, 1996. View at Publisher · View at Google Scholar
  41. S Eiling, S Lischner, J-O Busch, D Rothaupt, E Christophers, and A Hauschild, “Complete remission of a radio-resistant cutaneous angiosarcoma of the scalp by systemic treatment with liposomal doxorubicin,” British Journal of Dermatology, vol. 147, no. 1, pp. 150–153, 2002. View at Publisher · View at Google Scholar
  42. F Fata, E O'Reilly, D Ilson et al., “Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face,” Cancer, vol. 86, no. 10, pp. 2034–2037, 1999. View at Publisher · View at Google Scholar
  43. T Vogt, C Hafner, K Bross et al., “Antiangiogenetic therapy with pioglitazone, rofecoxib, and metronomic trofosfamide in patients with advanced malignant vascular tumors,” Cancer, vol. 98, no. 10, pp. 2251–2256, 2003. View at Publisher · View at Google Scholar
  44. T Ohguri, H Imada, S Nomoto et al., “Angiosarcoma of the scalp treated with curative radiotherapy plus recombinant interleukin-2 immunotherapy,” International Journal of Radiation Oncology, Biology, Physics, vol. 61, no. 5, pp. 1446–1453, 2005. View at Publisher · View at Google Scholar
  45. R Sasaki, T Soejima, K Kishi et al., “Angiosarcoma treated with radiotherapy: impact of tumor type and size on outcome,” International Journal of Radiation Oncology, Biology, Physics, vol. 52, no. 4, pp. 1032–1040, 2002. View at Publisher · View at Google Scholar
  46. J Ulrich, M Krause, A Brachmann, I Franke, and H Gollnick, “Successful treatment of angiosarcoma of the scalp by intralesional cytokine therapy and surface irradiation,” Journal of the European Academy of Dermatology and Venereology, vol. 14, no. 5, pp. 412–415, 2000. View at Publisher · View at Google Scholar
  47. M M Mareel, G A Storme, G K De Bruyne, and R M Van Cauwenberge, “Vinblastine, vincristine and vindesine: anti-invasive effect on MO4 mouse fibrosarcoma cells in vitro,” European Journal of Cancer and Clinical Oncology, vol. 18, no. 2, pp. 199–210, 1982. View at Publisher · View at Google Scholar
  48. N Jha, M McNeese, H T Jr Barkley, and J Kong, “Does radiotherapy have a role in hemangiopericytoma management? Report of 14 new cases and a review of the literature,” International Journal of Radiation Oncology, Biology, Physics, vol. 13, no. 9, pp. 1399–1402, 1987. View at Google Scholar
  49. J J Staples, R A Robinson, B-C Wen, and D H Hussey, “Hemangiopericytoma - the role of radiotherapy,” International Journal of Radiation Oncology, Biology, Physics, vol. 19, no. 2, pp. 445–451, 1990. View at Google Scholar
  50. F Schier and P Langhans, “Hemangiopericytoma - a review of the literature of 686 cases including 94 of children,” TumorDiagnostik & Therapie, vol. 8, pp. 1–4, 1987. View at Google Scholar
  51. S Gripp, H Pape, and G Schmitt, “Chondrosarcoma of the larynx: the role of radiotherapy revisited—a case report and review of the literature,” Cancer, vol. 82, no. 1, pp. 108–115, 1998. View at Publisher · View at Google Scholar
  52. L DR Thompson and F H Gannon, “Chondrosarcoma of the larynx: a clinicopathologic study of 111 cases with a review of the literature,” American Journal of Surgical Pathology, vol. 26, no. 7, pp. 836–851, 2002. View at Publisher · View at Google Scholar
  53. A M Berson, J R Castro, P Petti et al., “Charged particle irradiation of chordoma and chondrosarcoma of the base of skull and cervical spine: the Lawrence Berkeley Laboratory experience,” International Journal of Radiation Oncology, Biology, Physics, vol. 15, no. 3, pp. 559–565, 1988. View at Google Scholar
  54. H A Crockard, T Cheeseman, T Steel et al., “A multidisciplinary team approach to skull base chondrosarcomas,” Journal of Neurosurgery, vol. 95, no. 2, pp. 184–189, 2001. View at Google Scholar
  55. A R Harwood, J I Krajbich, and V L Fornasier, “Radiotherapy of chondrosarcoma of bone,” Cancer, vol. 45, no. 11, pp. 2769–2777, 1980. View at Publisher · View at Google Scholar
  56. G E Laramore, J T Griffith, M Boespflug et al., “Fast neutron radiotherapy for sarcomas of soft tissue, bone, and cartilage,” American Journal of Clinical Oncology, vol. 12, no. 4, pp. 320–325, 1989. View at Publisher · View at Google Scholar
  57. D McNaney, R D Lindberg, A G Ayala, H T Jr Barkley, and D H Hussey, “Fifteen year radiotherapy experience with chondrosarcoma of bone,” International Journal of Radiation Oncology, Biology, Physics, vol. 8, no. 2, pp. 187–190, 1982. View at Google Scholar
  58. R DH Ryall, T Bates, K A Newton, and K Hellmann, “Combination of radiotherapy and razoxane (ICRF 159) for chondrosarcoma,” Cancer, vol. 44, no. 3, pp. 891–895, 1979. View at Publisher · View at Google Scholar
  59. D C Weber, H P Rutz, E S Pedroni et al., “Results of spot-scanning proton radiation therapy for chordoma and chondrosarcoma of the skull base: the Paul Scherrer Institut experience,” International Journal of Radiation Oncology, Biology, Physics, vol. 63, no. 2, pp. 401–409, 2005. View at Publisher · View at Google Scholar
  60. B J Cummings, D I Hodson, and R S Bush, “Chordoma: the results of megavoltage radiation therapy,” International Journal of Radiation Oncology, Biology, Physics, vol. 9, no. 5, pp. 633–642, 1983. View at Google Scholar
  61. C Catton, B O'Sullivan, R Bell et al., “Chordoma: long-term follow-up after radical photon irradiation,” Radiotherapy and Oncology, vol. 41, no. 1, pp. 67–70, 1996. View at Google Scholar
  62. D B Fuller and J G Bloom, “Radiotherapy for chordoma,” International Journal of Radiation Oncology, Biology, Physics, vol. 15, no. 2, pp. 331–339, 1988. View at Publisher · View at Google Scholar
  63. C Glanzmann and W Horst, “Ergebnisse der Strahlentherapie bei Chordomen,” Strahlentherapie, vol. 154, no. 2, pp. 85–88, 1978. View at Google Scholar
  64. M E Keisch, D M Garcia, and R B Shibuya, “Retrospective long-term follow-up analysis in 21 patients with chordomas of various sites treated at a single institution,” Journal of Neurosurgery, vol. 75, no. 3, pp. 374–377, 1991. View at Google Scholar
  65. “The Proton Therapy Working Party. Proton therapy for base of skull chordoma: a report for the Royal College of Radiologists,” Clinical Oncology (Royal College of Radiologists), vol. 12, no. 2, pp. 75–79, 2000.
  66. W Rhomberg, F-K Böhler, H Novak, S Dertinger, and G Breitfellner, “A small prospective study of chordomas treated with radiotherapy and razoxane,” Strahlentherapie und Onkologie, vol. 179, no. 4, pp. 249–253, 2003. View at Publisher · View at Google Scholar
  67. B Raney, L Schnaufer, M Ziegler, J Chatten, P Littman, P Jarrett et al., “Treatment of children with neurogenic sarcoma. Experience at the Children's Hospital of Philadelphia, 1958–1984,” Cancer, vol. 59, no. 1, pp. 1–5, 1987. View at Publisher · View at Google Scholar
  68. A Ferrari, M Casanova, G Bisogno et al., “Clear cell sarcoma of tendons and aponeuroses in pediatric patients. A report from the Italian and German soft tissue sarcoma cooperative group,” Cancer, vol. 94, no. 12, pp. 3269–3276, 2002. View at Publisher · View at Google Scholar
  69. D S Shimm and H D Suit, “Radiation therapy of epithelioid sarcoma,” Cancer, vol. 52, no. 6, pp. 1022–1025, 1983. View at Publisher · View at Google Scholar
  70. T F DeLaney, I J Spiro, H D Suit et al., “Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas,” International Journal of Radiation Oncology, Biology, Physics, vol. 56, no. 4, pp. 1117–1127, 2003. View at Publisher · View at Google Scholar
  71. P WT Pisters, S R Patel, V G Prieto et al., “Phase I trial of preoperative doxorubicin-based concurrent chemoradiation and surgical resection for localized extremity and body wall soft tissue sarcomas,” Journal of Clinical Oncology, vol. 22, no. 16, pp. 3375–3380, 2004. View at Publisher · View at Google Scholar
  72. R Sauer, U Schuchardt, W Hohenberger et al., “Preoperative radiochemotherapy in soft tissue sarcomas for improving local tumor control and postoperative functional outcome,” Strahlentherapie und Onkologie, vol. 175, no. 6, pp. 259–266, 1999. View at Google Scholar
  73. K Hellmann and G E Murkin, “Synergism of ICRF 159 and radiotherapy in treatment of experimental tumors,” Cancer, vol. 34, no. 4, pp. 1033–1039, 1974. View at Publisher · View at Google Scholar
  74. K Hellmann and K Burrage, “Control of malignant metastases by ICRF l59,” Nature, vol. 224, no. 216, pp. 273–275, 1969. View at Publisher · View at Google Scholar
  75. A W Le Serve and K Hellmann, “Metastases and the normalization of tumour blood vessels by ICRF 159: a new type of drug action,” British Medical Journal, vol. 1, no. 800, pp. 597–601, 1972. View at Google Scholar
  76. K Hellmann, “Dynamics of tumour angiogenesis: effect of razoxane-induced growth rate slowdown,” Clinical and Experimental Metastasis, vol. 20, no. 2, pp. 95–102, 2003. View at Publisher · View at Google Scholar
  77. M T Bakowski, “ICRF 159, (+/-) 1,2-di(3,5-dioxopiperazin-1-yl) propane NSC-129,943; razoxane,” Cancer Treatment Reviews, vol. 3, no. 2, pp. 95–107, 1976. View at Publisher · View at Google Scholar · View at PubMed
  78. K Tanabe, Y Ikegami, R Ishida, and T Andoh, “Inhibition of topoisomerase II by antitumor agents bis(2,6-dioxopiperazine) derivatives,” Cancer Research, vol. 51, no. 18, pp. 4903–4908, 1991. View at Google Scholar